Ambalal Sarabhai, a company in the Pharmaceuticals industry, reported revenue of ₹58 crore and net profit of ₹0.67 crore for the September 2026 quarter.
Ambalal Sarabhai (NSE: AMBALALSA-BE) closed at ₹38.90 on 20 Nov 2026, up 30.1% over the past year. Its market capitalisation is ₹298 crore and it trades at 19.3 times earnings.
Incorporated in 1977, Ambalal Sarabhai Enterprises Ltd is in the business of manufacturing Pharmaceuticals and Electronics
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.